News Digest / Ticker: ALMS

Ticker: ALMS

05:05pm, Wednesday, Aug 13, 2025

Alumis adds lonigutamab and ~$486M liquidity via ACELYRIN merger; heavy R&D burn fuels losses

Snapshot - Alumis Inc. (NASDAQ: ALMS) What's happening inside: management completed the ACELYRIN merger (closed May 21, 2025), added lonigutamab and ~ $238.1M of equity consideration, materially strengthened liquid resources, but is simultaneously ramping R&D and integration costs that drove subs...